This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Repligen Corporation Acts To Prevent Proxy Proposal That Would Benefit Shareholders

CHICAGO, April 11, 2012 /PRNewswire/ -- Ronald L. Chez, a private investor who owns 9.2% of Repligen, submitted a proxy proposal to reduce the threshold of shareholder approval necessary to call a special meeting from the holders of a majority of Repligen (Nasdaq: RGEN) stock to 20%.  On April 4, 2012 Repligen filed a rejection request with the Securities and Exchange Commission (SEC) regarding the proposal.  "My proposal warrants a vote by all shareholders rather than what I believe to be a convoluted and dismissive response by a board that owns only 5.8% of the company," said Mr. Chez.

Mr. Chez has responded to the SEC with regard to repeated actions of Repligen attempting to deny his shareholder friendly proposal for inclusion in Repligen's 2012 proxy statement.  The matter is currently under review by the SEC.

"In previous meetings, correspondence and telephone calls, Repligen's Board consistently expressed their appreciative and positive response to my suggestions, and their desire to work with me in a cooperative manner to enhance shareholder value,"  stated Mr. Chez. However, "since my March 5, 2012 letter to the co-Chairperson of Repligen's board (available for review in my Schedule 13-D also filed on that date), the directors have refused to communicate with me despite my numerous attempts to do so."

Mr. Chez added, "Repligen's management has recently made several decisions that have the potential to deliver positive operating results after 10 years of lackluster performance and resultant shareholder frustration.  Until very recently, Repligen's stock price was essentially flat with its price a decade ago.  I believe the management, with constructive involvement by a Board with strong operating and entrepreneurial experience, has significant opportunities to build a strong, sustainably profitable company."

"It would appear that the directors of Repligen are resistant to a fresh perspective.  The directors wish to perpetuate their position when, with the exception only of Dr. Herlihy and one other director, they have almost 'no skin in the game'.  If the current directors (who own only 3.5% of the company excluding Dr. Herlihy's shares) are the right stewards for Repligen, there is no reason, other than further efforts to entrench themselves, to try to obviate this proposal.  It would appear that the directors are resistant to a fresh perspective that could benefit Repligen and its shareholders."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs